Clinical Trials Browser

NCT07530445 2026-04-15

Phase II Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Albumin-Bound Paclitaxel and Lenvatinib as Second-Line Therapy for Unresectable or Metastatic Biliary Tract Cancer

Phase 2 Recruiting

40 enrolled

Gastrointestinal

Biliary Tract Neoplasms

NCT07108114 2026-02-23

SLV-324 Treatment of Metastatic Solid Tumors

Phase 1 Recruiting

70 enrolled

Other solid neoplasm

Metastatic Solid Tumors

NCT07286253 2025-12-16

QL1706 Plus Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer: A Phase II Trial

Phase 2 Recruiting

50 enrolled

Gynecologic

Neoadjuvant Treatment for Locally Advanced Cervical Cancer

NCT07272590 2025-12-09

Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors

Phase 1/2 Not yet recruiting

290 enrolled

Other solid neoplasm

Metastatic Solid Tumors

NCT07243691 2025-11-24

Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma

Phase NA Recruiting

33 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT06490718 2025-09-08

Comparing Quality of Recovery Between ESPB and IV Lidocaine After Major Breast Cancer Surgery

Phase NA Completed

80 enrolled

Breast

Breast Neoplasms

NCT04099797 2025-09-04

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

Phase 1 Recruiting

37 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Glioma, Neoplasms, Germ Cell and Embryonal, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

NCT06505837 2025-08-28

JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）

Phase 3 Active not recruiting

395 enrolled

Thoracic

Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer

NCT03850574 2025-08-26

TUSCANY

Phase 1/2 Recruiting

240 enrolled

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT05894889 2025-07-23

Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC

Phase 2 Active not recruiting

70 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07024030 2025-06-17

DGPR1008

Phase 2 Completed

24 enrolled

Genitourinary

Prostate Cancer Patients Undergoing Radical Prostatectomy